Abbott (ABT) and AstraZeneca (AZN) to Co-Promote CRESTOR(R)
More News related to ABT
- Abbott Labs (ABT) Reaches Settlements in Litigation Related to Direct Purchaser Class Action; to Pay $184M
- Beacon Equity Issues Technical Trade Alerts on Drug Manufacturers: NVS, JNJ, PFE, GSK, ABT, AZN
- Holiday travelers beware: Every 50 seconds a laptop goes missing at U.S. airports(1)
- Short Seller Chanos Eyes Medical Sector
- Abbott Honored as One of The Deal's Most Admired Corporate Dealmakers
More News related to AZN
- Par Pharmaceutical (PRX) Halts Shipments of of Budesonide Inhalation Suspension
- Court Grants AstraZeneca (AZN) Request for Temporary Restrain on Further Sales of Teva's (TEVA) Generic Version of Pulmicort
- Beacon Equity Issues Technical Trade Alerts on Drug Manufacturers: NVS, JNJ, PFE, GSK, ABT, AZN
- AstraZeneca (AZN) Sees FY08 Adj-EPS at Low End of $4.90-$5.05 Range
- AstraZeneca Appoints Rich Fante as President of its U.S. Business
More News related to Corporate News
- The Hartford (HIG) Talks About Its Highly Rated CMBS Portfolio
- PepsiCo (PEP) to Invest $3 Billion in Mexico Operations
- Quicksilver Resources (KWK) Announces '09 Capital Budget
- Cosi, Inc. (COSI) Forms Special Committee to Review Strategic Alternatives
- Par Pharmaceutical (PRX) Halts Shipments of of Budesonide Inhalation Suspension
Abbott (NYSE: ABT) and AstraZeneca (NYSE: AZN) today announced that they have entered into an agreement for Abbott to promote AstraZeneca's CRESTOR(R), a medication used along with diet to reduce high cholesterol.
Under the terms of the agreement, Abbott will obtain the non-exclusive right to promote CRESTOR alongside AstraZeneca in the United States, excluding Puerto Rico. Specific financial terms were not disclosed.
Abbott Laboratories engages in the development, manufacture, and sale of health care products worldwide.
AstraZeneca PLC discovers, develops, manufactures, and markets prescription pharmaceuticals, biologics, and vaccines in the areas of cardiovascular, gastrointestinal, neuroscience, oncology, respiratory and inflammation, and infection worldwide.
Related Categories
Corporate NewsStocks Mentioned
-4.17Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
